| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |